Efficacy of antivirals and monoclonal antibodies for outpatient treatment of COVID-19 infection with the Omicron variant of SARS-CoV-2 coronavirus.
Gilead Sciences
Posted inClinical Trials, Infections, New Drugs, Regulatory
Hepcludex: Effective Treatment for Chronic Hepatitis D
Bulevirtide is the only approved antiviral drug against hepatitis delta.
Posted inInfections, New Drugs, Regulatory
Apretude: New Drug to Prevent HIV Infection
Injecting cabotegravir once every two months will high effectively protect against HIV infection.
Posted inInfections, Pharma & Biotech
HIV Treatment: One Pill Once a Week
Lenacapavir plus islatravir is a new level of highly active antiretroviral therapy for human immunodeficiency virus infection. Gilead Sciences and Merck & Co. continue their in-depth scientific research.
